Zimmer & Peacock
Z&P is a valued partner in Spermosens Development Team on the development of a disposable chip for the rapid assessment of male fertility based on Spermosens’ IP around the direct measurement of spermatozoa within the semen, and prediction of the fusion capacity to the oocyte (egg cell).
Z&P has deep knowledge in, and experience from, the development of electrochemical biosensors, and these capabilities are being leveraged by Spermosens to deliver a product to the market, in an investment efficient manner, leveraging capital insertion with ROI.
Spermosens understanding of the fertility market, and the patent pending platform technology will supply the answer to solving problems within the IVF market. Spermosens male-fertility diagnostic products are expected to lead to fewer cycles performed to fertilisation and conception.
…we are thrilled to be selected as a trusted development partner with Spermosens and delighted to be guided by Spermosens mission . We are impressed by Spermosens break-through technology and their go-to-market strategy.
– Z&P CEO Mr. Even Zimmer